FINDINGS:
Lungs: No focal consolidation or suspicious pulmonary nodules. No pneumothorax. <6 mm well-circumscribed nodule.
Mediastinum: Enlarged right hilar lymph node, short axis 0.9 cm. Cardiomediastinal contours within normal limits. no pathologic mediastinal lymphadenopathy.
Pleura/Pleural spaces: No pleural effusion or pleural thickening.
Great vessels/Aorta: No thoracic aortic aneurysm or dissection. aorta normal caliber.
Liver: 5.6 cm spiculated hepatic mass in segment 4 of the liver (hypoenhancing). No focal hepatic lesions. Normal attenuation. Postsurgical change: resection margin changes.
Spleen: Normal in size and attenuation. No focal splenic lesion.
Pancreas: Normal pancreatic contour and enhancement. No focal mass.
Adrenal glands: Adrenal glands are normal without nodules. no adrenal nodule.
Kidneys: No hydronephrosis. No enhancing renal mass.
GI tract/Bowel: No obstructive process. No focal bowel wall mass identified. no colonic mass.
Mesentery/Omentum: No ascites. No omental caking.
Mesenteric vessels (SMA/SMV): SMA/SMV are patent without thrombosis.
Urinary bladder: Unremarkable.
Reproductive organs: No adnexal mass. Uterus/prostate within expected size for age.
Lymph nodes: Enlarged porta hepatis lymph node, short axis 1.4 cm with central necrosis. Enlarged external iliac lymph node, short axis 2.6 cm. No pathologically enlarged lymph nodes by size criteria.
Bones/Osseous structures: No aggressive osseous lesion. No acute fracture.

IMPRESSION:
- Liver primary malignancy at segment 4 of the liver measuring approximately 56 mm.
- Findings concerning for nodal involvement.
- No definite distant metastases identified.
- RECIST 1.1 Summary:
- Target lesions (n=2; ≤2 per organ rule applied).
  • T1: Primary — 56 mm (longest diameter) at baseline.
  • T2: Lymph node — 26 mm (short axis) at baseline.
- SLD baseline: 82 mm.
- New lesions: absent (unequivocal).
- - RECIST 1.1 overall response category: Baseline (no category).
